Is Telmisartan equivalent to Losartan plus Hydrochlorothiazide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, Telmisartan is not equivalent to Losartan plus Hydrochlorothiazide (HCTZ). Telmisartan and Losartan are both angiotensin II receptor blockers (ARBs) used to treat high blood pressure, but they are different medications:

  • Telmisartan is a standalone ARB medication, with a usual dose range of 20-80 mg/d and a daily frequency of 1, as stated in the 2018 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults 1.
  • Losartan with HCTZ is a combination medication that includes an ARB (Losartan) and a diuretic (HCTZ), with Losartan having a usual dose range of 50-100 mg/d and a daily frequency of 1 or 2, and HCTZ having a usual dose range of 25-50 mg/d and a daily frequency of 1, as stated in the same guideline 1. While both medications work to lower blood pressure, they have different active ingredients and may be prescribed in different situations. Some studies have compared the effects of different antihypertensive medication classes, including ARBs and diuretics, on cardiovascular outcomes in patients with chronic kidney disease (CKD) 1. Additionally, guidelines have discussed the use of combination therapy, including ARBs and diuretics, in the management of hypertension, highlighting the importance of considering the specific needs and characteristics of each patient 1. It's crucial to take these medications exactly as prescribed by your doctor, as they have different dosages and potential side effects, and to consult your healthcare provider before making any changes to your medication regimen.

From the FDA Drug Label

The antihypertensive effect of telmisartan is not influenced by patient age, gender, weight, or body mass index. In a controlled study, the addition of telmisartan to hydrochlorothiazide produced an additional dose-related reduction in blood pressure that was similar in magnitude to the reduction achieved with telmisartan monotherapy. Hydrochlorothiazide also had an added blood pressure effect when added to telmisartan

The FDA drug label does not directly compare the efficacy of Telmisartan to Losartan plus Hydrochlorothiazide. Therefore, it is not possible to conclude that Telmisartan is equivalent to Losartan plus Hydrochlorothiazide based on the provided information 2.

From the Research

Comparison of Telmisartan and Losartan plus Hydrochlorothiazide

  • The efficacy of telmisartan compared to losartan plus hydrochlorothiazide has been studied in several clinical trials 3, 4, 5, 6, 7.
  • Telmisartan/hydrochlorothiazide combination therapy has been shown to provide significantly greater reductions in blood pressure than losartan plus hydrochlorothiazide in some studies 3, 4.
  • A study found that telmisartan 80 mg/HCTZ 12.5 mg reduced mean ambulatory diastolic blood pressure to a greater extent than losartan 50 mg/HCTZ 12.5 mg 4.
  • Another study found that telmisartan 80 mg/day was more effective than losartan 50 mg/day plus hydrochlorothiazide 12.5 mg over the last 6 hours of the dosage interval and the whole 24-hour postdose interval 5.
  • However, a study found that combination therapy with high-dose losartan and HCTZ was superior to the combination of telmisartan and HCTZ with respect to significant decreases in systolic blood pressure and serum uric acid in hypertensive patients 6.
  • The antihypertensive efficacy of once-daily telmisartan/HCTZ has been demonstrated in several large, randomized trials in patients with stages 1 and 2 hypertension, and the addition of HCTZ to telmisartan achieved significant reductions in BP in nonresponders to telmisartan monotherapy 7.

Key Findings

  • Telmisartan/HCTZ provides significantly greater reductions in blood pressure than monotherapy 3.
  • Telmisartan/HCTZ is effective and well-tolerated in the elderly, diabetics, and African-American patients 3.
  • The reduction in blood pressure achieved by adding HCTZ to telmisartan is greater than that achieved by adding HCTZ to atenolol 3.
  • Telmisartan 40 to 120 mg/day was as effective as amlodipine 5 to 10 mg/day or atenolol 50 to 100 mg/day in dose-titration studies 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.